Scrub typhus association with autoimmune biomarkers and clinical implications
PLOS Neglected Tropical Diseases · 2025
DOI: 10.1371/journal.pntd.0012766 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Hwanseung You und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jeonbuk National University Medical School, Jeonju, Republic of Korea. Hauptthemen laut MEDLINE: Scrub Typhus, Biomarkers, Antibodies, Antinuclear. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biomedical Research Institute, Jeonbuk National University Hospital, Ministry of Education.
Abstract (Originalsprache)
Background
Scrub typhus, a disease caused by Orientia tsutsugamushi , triggers systemic vasculitis and is prevalent in Eastern and Southern Asia. This study aimed to uncover the relationship between scrub typhus and autoimmune responses, focusing on antinuclear antibodies (ANAs) and the implications of elevated ANA titers during infection.
Method
Data from a total of 139 patients diagnosed with scrub typhus and 30 healthy controls were retrospectively analyzed through serum samples to assess the levels of ANAs and related autoantibodies. The study further examined the temporal variation of these antibody titers in relation to post-symptom progression and evaluated their association with clinical and laboratory parameters.
Results
The study results detail significant differences in autoimmune responses between scrub typhus patients and healthy controls. ANA titers above 1:80 were detected in 71.2% of patients; these titers were elevated in only 13.3% of the healthy controls. High-titer positivity (1:640 or higher) was observed exclusively in the scrub typhus group. The distribution of ANA titers revealed a progressive increase in mean ANA and double-stranded deoxyribonucleic acid Immunoglobulin M (anti-dsDNA IgM) titers as the duration after symptom onset increased, indicating an augmented immune response over time. This trend was observed along with a systematic elevation in median anti-dsDNA IgM titers, highlighting the dynamic nature of immune responses in scrub typhus infection.
Conclusion
Our findings conclude a substantial autoimmunological reaction in scrub typhus patients, suggesting potential mimicry of autoimmune conditions like Systemic Lupus Erythematosus. These results underline the complex interplay between infectious diseases and autoimmunity, emphasizing the necessity for further research into these mechanisms and their clinical implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jeonbuk National University Medical School, Jeonju, Republic of Korea.
- Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Republic of Korea.
- Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Republic of Korea.
ORCID-Profile: Yunjung Choi, Chang-Seop Lee
Förderung
- Biomedical Research Institute, Jeonbuk National University Hospital
- Ministry of Education
Zitieren
APA
You, H., Song, J., Kim, S., Oh, S. M., Hwang, J. H., Hwang, J. H., Yoo, W. H., Choi, Y., & Lee, C. S. (2025). Scrub typhus association with autoimmune biomarkers and clinical implications. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012766
Vancouver
You H, Song J, Kim S, Oh SM, Hwang JH, Hwang JH, et al. Scrub typhus association with autoimmune biomarkers and clinical implications. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0012766
BibTeX
@article{You2025,
author = {You, Hwanseung and Song, Jeongeun and Kim, Seonglyeong and Oh, Sang-Min and Hwang, Joo-Hee and Hwang, Jeong-Hwan and Yoo, Wan-Hee and Choi, Yunjung and Lee, Chang-Seop},
title = {Scrub typhus association with autoimmune biomarkers and clinical implications},
journal = {PLOS Neglected Tropical Diseases},
year = {2025},
doi = {10.1371/journal.pntd.0012766}
}
EUVIMED